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Abstract
Background: Infectious diseases are significant causes of morbidity and mortality among elderly populations.
However, the relationship between oxidative stress, immune function and inflammatory response in acute phase of
the infectious disease is poorly understood.
Results: Herein the abundance of a selection of 148 transcripts involved in immunosenescence and stress
response was compared in total RNA of PBMC of 28 healthy aged probands and 39 aged patients in acute phase
of infectious disease (day 2-4 after hospitalization) or in convalescence phase (day 7-10). This study provides a list
of 24 differentially abundant transcript species in the acute phase versus healthy aged. For instance, transcripts
associated with inflammatory and anti-inflammatory reactions (TNFRSF1A, IL1R1, IL1R2, IL10RB) and with oxidative
stress (HMOX1, GPX1, SOD2, PRDX6) were more abundant while those associated with T-cell functions (CD28,
CD69, LCK) were less abundant in acute phase. The abundance of seven of these transcripts (CD28, CD69, LCK,
CTSD, HMOX1, TNFRSF1A and PRDX6) was already known to be altered in healthy aged probands compared to
healthy young ones and was further affected in aged patients in acute phase, compromising an efficient response.
Conclusion: This work provides insights of the state of acute phase response to infections in elderly patients and
could explain further the lack of appropriate response in the elderly compared to younger persons.
Introduction
Ageing is defined as a progressive deterioration of biolo-
gical functions and physiological capacity, which leads
to the accumulation of disabilities and diseases [1] with
reduced ability to cope with environmental stimuli, dys-
regulated inflammatory responses and changes of the
immune response. Immunosenescence refers to the gra-
dual age-related deterioration or modification of the
immune system [2]. This results in greater susceptibility
to the risk of infectious diseases, inflammatory disorders,
cancer and autoimmune diseases [3,4]. Immunosenes-
cence is involved in the poor response of elderly to vac-
cination against pathogens such as influenza or
pneumonia [5-7]. Ageing is associated with increased
levels of circulating inflammatory components and
chronic pro-inflammatory state, so called inflammageing
[8], due to continuous antigenic stress that impinges
upon innate immunity, throughout life, and has poten-
tial implications for the onset of inflammatory diseases
[9]. While inflammation is an adaptive response to acute
illness or injury, resulting in clearance of pathogens,
inflammageing can be detrimental to health and be pre-
disposing factor for age-related diseases. A higher level
of pro-inflammatory cytokines is associated with a num-
ber of age-related diseases and/or with the development
of frailty [10,11].
Infectious diseases are significant causes of morbidity
and mortality among elderly population. Older persons
generally have greater susceptibility to infections than
younger adults [12]. This is particularly true with intra-
cellular micro-organisms whose immunity is mostly cell-
mediated. It is well known that ageing is associated with
immunosenescence. However, other factors probably
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its adverse impact on host response in the elderly per-
sons. Here, we used a transcriptomic approach to iden-
tify “signature genes” of acute phase response to
infections in the peripheral blood mononuclear cell
(PBMC) of the elderly persons. Using a designed gene
expression micro-array, we reported the data analysis of
samples collected from healthy aged probands and aged
infectious patients during their acute and convalescence
phases. The purpose of this study was to investigate
insights of oxidative stress, immune function and
inflammatory responses in acute phase response to
infections in elderly. Hence, we developed a low-density
DNA array to study the relative abundance of tran-
scripts species involved in immunosenescence, inflam-
mation and stress response, mainly based on the
literature and as described in [13]. Inter- and intra-plat-
form reproducibility of gene expression measurements
was demonstrated previously with this technology
[14,15]. Numerous verifications with real time retrotran-
scription quantitative polymerase chain reaction (RT-
qPCR) have been done in different studies on senes-
cence [16]. Verifications of results obtained with these
arrays in very similar conditions using samples of total
RNA from PBMC of old and young probands were also
done [13].
Methods
The recruitment was conducted at the University Hospi-
tal of Mont-Godinne (UCL, Belgium). Two groups were
considered: aged healthy volunteers considered as con-
trol group and aged patients with infectious diseases.
Healthy aged participants were recruited on a voluntary
basis from different senior associations. To be eligible,
participants needed: 1) to be aged of 75 years and over;
2 )n o tt ob ei n s t i t u t i o n a l i s e d ;3 )t oh a v en oe v i d e n c ei n
the previous month of an acute medical condition, nor
deterioration of a chronic condition. The aged patients
with infectious diseases were older than 75 years and
were hospitalized through the emergency department,
with documented infection (bacteriological and/or radi-
ological proofs), including pneumonia, diverticulitis, sep-
ticaemia or cellulitis. Patients were excluded if they used
steroidal or nonsteroidal anti-inflammatory drugs one
week before the inclusion (low doses of aspirin for car-
diovascular prevention were tolerated), had active cancer
or a previous hospital stay within the 2 previous weeks,
were admitted for intensive or palliative care or were
completely dependent in activities of daily living (ADL).
The same aged infectious patients were evaluated and
blood was taken during acute phase (defined as day 2 to
4 after admission) and convalescence phase (day 7 to
10). Moreover, in the same study, we recruited 25
healthy young probands, as previously described [13].
Their mean age was 35.0 ± 6.5 year old. This study was
approved by the Ethical Committee of the hospital.
Informed consent was obtained from all volunteers.
2) Plasma, isolation of PBMC, RNA extraction and
integrity
After blood samples (16 ml) were collected, blood para-
meters including cell counts and assays of acute phase
proteins: C-reactive protein (CRP), albumin, prealbumin,
fibrinogen, D-dimers were routinely determined. The
levels of interleukin-6 (IL-6), interleukin-10 (IL-10),
tumor necrosis factor-alpha (TNF-a) were essayed by
ELISA (Biosource, Belgium). PBMC were isolated by
centrifugation on Ficoll-Hypaque gradient centrifugation
(Becton Dickinson Vacutainer CPT, USA). Plasma was
collected and stored at -80°C until analysis.
Cells were washed twice in HBSS buffer. After adjust-
ment at 10
8 cells/ml, part of the suspension was dis-
patched for hemogram determination (ADVIA 120,
Baker, USA). The rest was used for extraction of total
RNA (Total RNAgents® Total RNA Isolation System,
Promega, USA) according to the manufacturer’sp r o t o -
col and stored at -80°C. After extraction of total RNA,
the integrity of RNA was assessed (Agilent 2100 Bioana-
lyzer Agilent Technologies, Germany). Reverse tran-
scription, RNA amplification and labelling using the
MessageAmp™ II-Biotin Enhanced kit (Ambion, USA)
were performed from 250 ng of total RNA.
3) Low density DNA-array analysis
Design of the array
We purchased a low-density DNA array “on-demand”
able to detect 148 different transcript species (Eppen-
dorf, Germany) involved in immunosenescence, and
more specifically focusing the T-cell compartment,
inflammation and oxidative stress, as previously
described [13].
The system has two assays per glass side with three
identical sub-arrays per assay. The sequences of the
DNA covalently linked to the glass slide were carefully
chosen by sequence comparison. Checks were made to
ensure that no cross-hybridization takes place. Several
positive and negative hybridization controls plus detec-
tion controls were spotted on the array in order to con-
trol the reliability of the experimental data.
Hybridization and detection
Hybridization on the array was carried out as described
by the manufacturer using 15 μgo fc o m p l e m e n t a r y
DNA. The hybridization reaction was performed over-
night at 60°C in a Thermoblock for DC (DualChip®)
Slides used with a Thermomixer comfort (Eppendorf,
Germany).
Detection was performed using a Cy3-conjugated IgG
anti-biotin (Jackson Immuno Research Laboratories,
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scanned using the Packard ScanArray (PerkinElmer,
USA) at a resolution of 10 μm. To maximize the
dynamic range of detection, the same arrays were
scanned at three photomultiplier (PMT) gains for quan-
tifying high- and low-copy expressed genes. The
scanned 16-bit images were imported into the ImaGene
4.1 software (BioDiscovery, USA). The fluorescence
intensity of each DNA spot (median intensity of each
pixel present within the spot) was calculated using local
median background subtraction. Intensity values from
high-PMT-gain pictures were used, except in the case of
saturated spots. In the latter case, intensity values from
intermediate PMT-gain pictures (or from low PMT-gain
pictures in case of spots also saturated in the intermedi-
ate PMT-gain pictures) were used after scale correction.
Only spots with median intensity after background sub-
traction at least 2 fold higher than their local back-
ground were taken into account. The median of the
three intensity values of the triplicate DNA spots was
used in further steps.
Data normalization and inter-batch correction
All micro-arrays results were normalized against a single
reference applying a local weighted regression [17]. The
micro-arrays were provided in four batches. A systema-
tic intensity bias was detected between each batch and
was corrected successfully. Four samples were hybri-
dized four times onto arrays of the four different
batches. For each spotted sequence, a correction factor
between the first batch and each of the others was com-
puted using these four samples. This spot and batch
dependent correction factor was applied to normalize
intensities of each array. These normalized and cor-
rected intensities were used in further statistical analyses
as in [13].
4) Statistical analysis
The Mann Whitney test was used to compare the differ-
ence between the healthy participant and the patients
with infectious diseases groups. Comparisons between
acute and convalescence phase were performed using
Wilcoxon’s test. Data are expressed as mean ± SD. Sta-
tistically differentially abundant transcripts were
selected. We used p-values with the Benjamini correc-
tion (P-value × m/g, where m is the number of variables
and g the rank of the variable according to p-value) and
Benjamini < 0.05.
Results
The study involved 28 healthy volunteers, representing
the control group (mean age 82.3 ± 6.0, range 75 to
103). The 39 aged patients suffered from infectious dis-
eases, as described in materials and methods (mean age
81.8 ± 5.4, range 75 to 97). The two groups were
homogenous with regard to age and gender. Thirty-
three of the patients in acute phase (day 2-4) were
followed until convalescence phase (day 7-10) when
samples of blood were taken again.
1) Indicators of the acute-phase response
Serum levels of albumin, pre-albumin and number of
lymphocytes were significantly lower in blood of aged
patients with infectious diseases in acute phase com-
pared to the control healthy aged probands (Table 1).
The levels of IL-6, IL-10, TNF-a,C R P ,f i b r i n o g e n ,D -
dimer were significantly higher, compared with the con-
trol group. During convalescence phase, intermediate
levels were observed between the control group and the
aged patients with infectious diseases in acute phase
(Table 1). Number of lymphocytes was higher in conva-
lescence phase than in acute phase. Serum levels of
CRP, D-dimer, fibrinogen and IL-6 were lower in conva-
lescence phase than in acute phase. The total leukocyte
population and neutrophil numbers in blood were
higher in acute and convalescence phases compared to
control healthy aged group, with the highest values at
acute phase. The lymphocytes count was significantly
decreased in acute phase. The changes of serum levels
of CRP, D-dimer, fibrinogen, IL-6 and numbers of lym-
phocytes, leukocytes, neutrophils were significantly dif-
ferent between acute and convalescence phases. Thus,
the main indicators of acute phase were observed in the
aged patients with infectious diseases recruited at day
2-4 after hospitalization.
2) Identification of differentially abundant transcripts in
acute phase
The low-density DNA array used in this study was com-
posed 148 represented genes involved in immunosenes-
cence, inflammation, and stress response, mainly
selected from literature (list of these transcripts in Addi-
tional file 1, Table S1).
From the 148 transcript species including those of 13
housekeeping genes, 82 transcript species were detected
in the samples of PBMC of all the subjects, 15 transcript
species were not detectable in any of the subjects and 51
were not quantifiable. The 82 detected transcript species
were thus eligible for further analysis. There was no
situation where a transcript was detected in a condition
and not detected in the other. Validation of the results
obtained with these arrays by RT-qPCR was described
previously in the same conditions of blood sampling,
RNA collection and hybridization on these arrays [13].
To elucidate differences of the abundance of PBMC
transcripts between aged patients at acute phase and
healthy aged subjects, the results were analysed individu-
ally for the 82 eligible transcripts, using a Mann-Whitney
test, with a Benjamini and Hochberg false-discovery rate,
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tially abundant transcripts with 15 increases and 9
decreases. The list of these transcripts is shown in Table
2. From these transcripts, those for which abundance
decreased drastically were EGR3, CD69, LCK, BCL2 and
CD28, while IL1R2, SERPINB2, CLU and TIMP1
increased by more than 1.7 fold (Table 2). The abun-
dance of these 24 transcripts was compared between
acute and convalescence phases.
3) Comparison between acute and convalescence phase
At convalescence phase, one could sort out 3 classes of
transcripts among the those for which abundance
decreased in acute phase. Class 1 transcripts (BCL2,
CD28, CD69 and LCK) came back to the control values
of the healthy aged. In class 2 (CASP8, CCL5 and
D N A J B 1 ) ,t h e r ew a sas i g n i f i c a n tb u ti n c o m p l e t er e t u r n
to the control value, which was not observed for class 3
(DDIT3 and EGR3, Fig 1). Following a similar rationale,
the 15 transcripts whose abundance was increased in
acute phase could be sorted in 3 classes at convales-
cence phase (Fig 2, 3). Class 1 transcripts returned to
the control values of healthy aged (CTSD, CTSZ,
TIMP2, Fig 2). In class 2 (CLU, HMOX1, IL10RB,
IL1R1, IL1R2, SERPINB2, SOD2, TIMP1, TNFRSF1A),
the abundance of the transcripts significantly decreased
but did not return to control values (Fig 2, 3). In class 3
the abundance of the transcripts did not significantly
decrease at convalescence (GPX1, PRDX6 and PSMD1,
Fig 3).
Discussion
The elderly population is particularly susceptible to
infection and vulnerable in case of disease [18,19].
Declining immune function substantially contributes to
this higher susceptibility to develop or to increase pre-
valence and severity of some infectious diseases. The
decline of immune defences with advanced age is well
documented, especially the T-cell function decline in
elderly person [13,20]. PBMC contain different cell
types with distinct functions and corresponding gene
expression profiles. The number of lymphocytes was
significantly lower in aged patients in acute phase of
infectious diseases. This could explain in part the
changes of transcripts levels of gene specifically
express in lymphocytes. However, the decrease of lym-
phocyte number was less marked than the large
decrease of transcript levels of CD28, CD69 and LCK.
In this study, we tried to identify transcriptomic bio-
markers of the acute phase of infections in elderly
patients. Healthy aged volunteers were used as control
group, with the same mean age, in order to avoid age-
related change of expression. Healthy aged probands
gave blood and aged patients with infectious diseases
gave blood twice, once in acute and once in convales-
cence phases. In the acute phase, a typical acute phase
response was observed with higher levels of CRP, fibri-
nogen, D-dimers, leukocytes, neutrophils, IL-6 and
TNF-a and lower level of albumin, pre-albumin and
lymphocytes, as classically described in the acute phase
response syndrome [21,22].
Table 1 Cell counts, plasma concentration of acute phase proteins and pro-inflammatory cytokines
Benjamini
HA (m±SD) AIA (m±SD) AIC (m±SD) AIA vs AIC AIA vs HA AIC vs HA
Cell counts (nb/μL)
Lymphocytes 1531.76 ± 464.12 1086.58 ± 417.70 1442.65 ± 459.67 p < 0.001 p < 0.001 p < 0.001
Leucocytes 5975.76 ± 998.45 10601.16 ± 4623.98 8083.78 ± 2379.13 p < 0.001 p < 0.001 p < 0.001
Neutrophils 3762.94 ± 891.50 8734.72 ± 4284.35 5702.68 ± 2040.11 p < 0.001 p < 0.001 p < 0.001
Acute phase proteins
Albumin (mg/dL) 4270.67 ± 443.31 2982.42 ± 483.71 ND p < 0.001
Prealbumin (mg/dL) 26.00 ± 4.74 10.69 ± 4.61 ND p < 0.001
CRP (mg/dL) 0.26 ± 0.41 18.34 ± 9.24 2.50 ± 3.45 p < 0.001 p < 0.001 p < 0.001
D-dimer (ng/mL) 647.22 ± 430.54 2442.90 ± 1692.26 1838.14 ± 1125.11 p < 0.05 p < 0.001 p < 0.05
Fibrinogen (mg/dL) 392.81 ± 65.54 752.09 ± 242.97 586.22 ± 172.04 p < 0.01 p < 0.001 p < 0.005
Pro-inflammatory cytokines
IL6 (pg/mL) 14.01 ± 26.95 121.84 ± 98.73 56.28 ± 71.23 p < 0.001 p < 0.005 p < 0.001
IL10 (pg/mL) 1.15 ± 3.67 17.95 ± 109.00 ND p < 0.001
TNF alpha (pg/mL) 22.80 ± 12.57 52.30 ± 45.88 ND p < 0.005
Values are expressed as mean ± SD. CRP: C-reactive protein; ND: Not Determined; Healthy Aged (HA); Aged patients with Infectious diseases in Acute phase (AIA);
Aged patients with Infectious diseases in Convalescence phase (AIC).
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patients (n = 39) versus healthy aged (HA) probands (n = 28)
Gene Symbol Gene Name Accession Number AIA/HA ratio Benjamini
BCL2 B-cell CLL/lymphoma 2 NM_000633.1 0.58 p < 0.001
CASP8 Caspase 8, apoptosis-related cysteine peptidase X98172.1 0.66 p < 0.001
CCL5 Chemokine (C-C motif) ligand 5 NM_002985.1 0.71 p < 0.001
CD28 CD28 antigen (Tp44) NM_006139.1 0.61 p < 0.005
CD69 CD69 antigen (p60, early T-cell activation antigen) NM_001781.1 0.44 p < 0.001
DDIT3 DNA-damage-inducible transcript 3 S40706.1 0.76 p < 0.01
DNAJB1 DnaJ (Hsp40) homolog, subfamily B, member 1 D49547.1 0.76 p < 0.001
EGR3 Early growth response 3 NM_004430.1 0.42 p < 0.05
LCK Lymphocyte-specific protein tyrosine kinase NM_005356.2 0.58 p < 0.001
CLU Clusterin J02908.1 1.79 p < 0.001
CTSD Cathepsin D (lysosomal aspartyl peptidase) M11233.1 1.50 p < 0.001
CTSZ Cathepsin Z AF136273.1 1.33 p < 0.05
GPX1 Glutathione peroxidase 1 M21304.1 1.21 p < 0.05
HMOX1 Heme oxygenase (decycling) 1 NM_002133.1 1.57 p < 0.001
IL10RB Interleukin 10 receptor, beta NM_000628.3 1.39 p < 0.001
IL1R1 Interleukin 1 receptor, type I NM_000877.2 1.48 p < 0.05
IL1R2 Interleukin 1 receptor, type II U74649.1 2.34 p < 0.001
PRDX6 Peroxiredoxin 6 NM_004905.1 1.23 p < 0.005
PSMD1 Proteasome (prosome, macropain) 26 S subunit, non-ATPase, 1 NM_002807.1 1.24 p < 0.001
SERPINB2 Serpin peptidase inhibitor, clade B (ovalbumin), member 2 J02685.1 2.17 p < 0.005
SOD2 Superoxide dismutase 2, mitochondrial NM_000636.1 1.53 p < 0.001
TIMP1 TIMP metallopeptidase inhibitor 1 NM_003254.1 1.71 p < 0.001
TIMP2 TIMP metallopeptidase inhibitor 2 NM_003255.2 1.59 p < 0.001
TNFRSF1A Tumor necrosis factor receptor superfamily, member 1A NM_001065.2 1.45 p < 0.001
Statistical analysis was carried out with the Mann-Whitney test.
Figure 1 Transcript species with decreased abundance in PMBC of Aged patients with Infectious diseases in Acute phase (AIA,
n = 39), compared with healthy aged (HA, n = 28) probands and with Aged patients with Infectious diseases in Convalescence phase
(AIC, n = 33). Transcripts are sorted according to 3 classes whether their abundance came back to the values of the control (healthy aged) at
convalescence (class 1), significantly changed towards the values of the control at convalescence without full return to the values control (class
2) or not (class 3). Results are given as means ± standard deviation. Statistical analysis were carried out by the Mann-Whitney test for comparison
between AIA and HA or AIC and HA, and by Wilcoxon’s test for comparison between AIC and AIA. NS: Non significant (p ≥ 0.05); * p < 0.05;
** p < 0.01; *** p < 0.001.
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Page 5 of 10Figure 2 Transcript species with increased abundance in PMBC of Aged patients with Infectious diseases in Acute phase (AIA, n = 39),
compared with healthy aged (HA, n = 28) probands and with Aged patients with Infectious diseases in Convalescence phase (AIC, n =
33). Transcripts are sorted according to 3 classes whether their abundance came back to the values of the control (healthy aged) at
convalescence (class 1, Figure 2), significantly changed towards the values of the control at convalescence without full return to the values
control (class 2, Figure 2 right and 3 left) or not (class 3, Figure 3 right). Results are given as means ± standard deviation. Statistical analysis were
carried out by the Mann-Whitney test for comparison between AIA and HA or AIC and HA, and by Wilcoxon’s test for comparison between AIC
and AIA. NS: Non significant (p ≥ 0.05); * p < 0.05; ** p < 0.01; *** p < 0.001.
Figure 3 Transcript species with increased abundance in PMBC of Aged patients with Infectious diseases in Acute phase (AIA, n = 39),
compared with healthy aged (HA, n = 28) probands and with Aged patients with Infectious diseases in Convalescence phase (AIC, n =
33). Transcripts are sorted according to 3 classes whether their abundance came back to the values of the control (healthy aged) at
convalescence (class 1, Figure 2), significantly changed towards the values of the control at convalescence without full return to the values
control (class 2, Figure 2 right and 3 left) or not (class 3, Figure 3 right). Results are given as means ± standard deviation. Statistical analysis were
carried out by the Mann-Whitney test for comparison between AIA and HA or AIC and HA, and by Wilcoxon’s test for comparison between AIC
and AIA. NS: Non significant (p ≥ 0.05); * p < 0.05; ** p < 0.01; *** p < 0.001.
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involved in stress response and immunosenescence,
more specially focusing the T-cell compartments, and
differentially abundant in the PBMC of old patients hos-
pitalized due to acute infectious disease. Among the 82
transcripts eligible for data mining, 24 transcripts were
differentially abundant with 15 more abundant and 9
less abundant in the PBMC of the infectious patients
compared to the healthy aged probands. The transcript
species whose abundance increased are known to be
involved in oxidative stress, pro-inflammatory and anti-
inflammatory response. The transcript species whose
abundance decreased are involved in T-cell functions.
At convalescence phase, 7 of these 24 transcripts came
back to the normal values of the healthy aged probands
(day 7-10), 12 significantly tended to come back to nor-
mal values while another 5 did not (DDIT3, EGR3,
PRDX6, GPX1 and PSMD1).
Acute phase response is associated with increased oxi-
dative stress. The transcript species of HMOX1, PRDX6,
GPX1 and SOD2 were more abundant in PBMC of
infected aged patients. HMOX1 gene encodes heme
oxygenase, which is associated with oxidative stress in
many cell types such as fibroblasts [23] and involved in
stress response [24-27]. PRDX6 is an antioxidant
enzyme overexpressed in stress-induced premature
senescence [28]. GPX1 and SOD2 are major antioxidant
enzymes [29,30] localised in the mitochondria (GPX1 is
also found in the cytoplasm). The increase of HMOX1,
PRDX6, GPX1 and SOD2 transcript species in PBMC of
aged patients in acute phase might be a compensatory
mechanism to cope with increased oxidative stress and
damage in acute phase response. We compared pre-
viously the level of HMOX1 transcript between healthy
young and healthy aged probands and found 1.46 fold
increase in the aged probands [13]. The cumulated
increase from healthy young probands to aged patients
i na c u t ep h a s er e p r e s e n t e da2 . 2 5f o l di n c r e a s e( T a b l e
3). As for PRDX6, the 23% decrease between aged and
young healthy probands was exactly counterbalanced by
the alteration observed between old healthy probands
and aged patients in acute phase. Nothing is known on
the induct ability of PRDX6 in young persons affected
by sepsis.
The acute phase response is frequently associated with
the activation of the inflammatory/anti-inflammatory
response. There was an increase of the transcript abun-
dance of the following cytokine receptors in infected
aged patients: IL1R2, IL10RB, IL1R1 and TNFRSF1A.
Among the 24 differentially transcripts identified here in
acute phase, the abundance of IL1R2 transcript dis-
played the most important expression in acutely aged
patients with infectious diseases (Fig 2). IL1R2, also
known as CD121b, acts as a decoy receptor that inhibits
the activity of its ligands [31] and inhibits IL-1 activity
by acting as a decoy target for IL-1 [32]. Similarly the
abundance of TNFRSF1A transcript was increased. Pre-
vious study showed that cytokine antagonist IL-1RA is
elevated in plasma of aged patients and IL-2 production
in vitro was lower with urinary tract infections com-
pared to healthy aged [33]. Their results suggested that
cytokine antagonists reduce IL-2 production and the
capability of T cells to proliferate, thereby inhibiting
responses in the elderly. Healthy aged also showed pro-
longed inflammatory activity in response to endotoxe-
mia in vivo compared to young subjects. This
phenomenon is probably due to changes in intensity to
feed-back-inhibitory mechanisms or to an imbalance
between the inflammatory and anti-inflammatory
response [34]. The receptor IL-10RB for IL-10 (which
binds also IL-22) serves as an accessory chain essential
for the active IL-10 receptor complex and to initiate IL-
10 induced signal transduction events. The abundance
of the transcript of IL10-RB increased in acute phase in
the aged patients. IL-10 is an anti-inflammatory cyto-
kine. IL-10 release was also increased (Table 1) in aged
patients in acute condition. Previous in vitro studies
showed that IL-10 exerts an inhibitory effect on the
expression of pro-inflammatory cytokines in PBMCs
[35,36]. Production of IL-10 also suppresses the adaptive
T-cell response [37]. IL-10 enhanced production is
believed to be an anti-inflammatory regulatory mechan-
ism by which the ageing immune system auto-regulates
the potential damage caused by its excessive activation
[38]. This modulates the intracellular signaling process
to favour the production of anti-inflammatory rather
than pro-inflammatory agents [39,40]. Taken together,
these results suggest an imbal a n c eb e t w e e nt h ei n f l a m -
matory (increased release of IL-6) and anti-inflammatory
(increased release of IL-10) responses in acute phase of
Table 3 Ratios of abundance of seven transcripts
between healthy aged (HA) and healthy young (HY)
probands, between Aged patients with Infectious
diseases in Acute phase (AIA) and HA and between AIA
and HY
Gene Symbol HA/HY AIA/HA AIA/HY
CD28 0.62 0.61 0.39
CD69 0.70 0.44 0.33
LCK 0.77 0.58 0.45
CTSD 1.37 1.5 2.00
HMOX1 1.46 1.57 2.15
TNFRSF1A 1.68 1.45 2.33
PRDX6 0.77 1.23 1.01
These seven transcripts were found to be differentially abundant between
PBMC of HA and HY [13].
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gical and biochemical age-related changes, this might
lead to a defective inflammatory response and then a
defective responsiveness of aged patient to the patho-
genic challenge [41].
The decline of the immune function is supported by
many epidemiologic and clinical observations [42,43]. In
this work, we observed a decreased abundance of CD28,
CD69 and LCK mRNA in acutely infected aged patients,
compared to healthy aged. The comparison of the levels
of CD28, CD69 and LCK transcripts between healthy
aged and healthy young probands previously showed a
respective 38%, 30% and 23% decrease in the aged pro-
bands [13]. Compared to healthy young probands, the
difference was respectively to 61%, 67% and 55% (Table
3). These dramatic alterations, if confirmed at protein
levels, might really affect T-cell activation. CD28 and
LCK molecules indicate TCR (T cell receptor) signaling
pathways. Interaction of the TCR with an antigen
induces a rapid early cascade of intracellular signaling
events that lead to T-cell activation. Nevertheless, the
binding of TCR to antigen alone is insufficient to drive
immune reaction. Co-stimulation is a critical step in
fully activating T cells. The accumulation of CD28-effec-
tor T-cells has been shown to accompany an impaired
response to influenza vaccination [44]. TCR engagement
recruits LCK and FYN, which are protein kinases initiat-
ing the TCR signaling pathway [45]. Decreased abun-
dance of CD28 and LCK mRNA indicates that early
signaling events following antigen stimulation are altered
in T lymphocytes. This hypothesis of lowered activation
was reinforced by the 66% decrease of the mRNA level
of early activation surface markers CD69 found in com-
parison with healthy aged subjects (Table 2). These
changes in the T-cell activation mechanisms probably
explain the lower efficiency of vaccination procedure
and the vulnerability in case of disease in old persons,
where TCR antigen recognition and T-cell activation are
primary phenomenon involved as well as higher infec-
tious risk when involving adaptive immune system.
We observed previously a 29% decrease of the number
of lymphocytes in the PBMC in aged patients. The
decrease of the mRNA level of CD28, CD69 or LCK
might be also linked in part to the decrease of the num-
ber of lymphocytes. Lastly, we also observed previously
a1 . 3 7f o l di n c r e a s eo ft h ea b u n d a n c eo fC T S Dt r a n -
script in healthy aged, compared with healthy young
probands [13]. The comparison of the level of CTSD
transcript showed a 2 fold increase between healthy
young probands and acutely aged patients with infec-
tious diseases (Table 3). CTSD gene codes for cathepsin
D, a lysosomal protease involved in physiological protein
degradation [46] and supposed to play role in antigen
processing [47].
In conclusion, the acute phase response to infections
is altered in elderly patients. Decreased abundance of
transcript species associated with T-cell functions and
increased abundances of transcript species associated
with inflammatory and anti-inflammatory responses in
acute phase suggest a decline of the immune function
and an impaired inflammatory responses. A better
insight into the basic mechanisms of immune dysfunc-
tion, changes of inflammatory response and oxidative
stress that occur in acute phase on aged patients will
help to intervene and thereby ensure a better protection
of the vulnerable elderly population from disease, subse-
quent loss of independence, and death.
It would be interesting to determine the abundance of
the corresponding proteins and to know whether the
abundance of all the transcripts of classes 2 and 3
returns to normal values later than day 7-10 or not.
This would require following the outcome and obtaining
blood of the patients for several weeks/months after
hospitalization, which is out of the scope of this study
and poses potential ethical problems.
Additional material
Additional file 1: Table S1 - Gene symbol, gene name and GenBank
accession number of all transcripts which abundance was
determined in this study. A specific technology of low-density DNA
arrays was used to study, in peripheral blood mononuclear cells, the
relative abundance of 135 transcripts species involved in
immunosenescence, inflammation and stress response plus 13
housekeeping genes. The list of the corresponding genes in given in this
additional file.
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